Tag: Deciphera Pharmaceuticals

Home / Deciphera Pharmaceuticals

Categories

Vimseltinib is approved by the USFDA for symptomatic tenosynovial giant cell tumor

On February 14, 2025, the Food and Drug Administration sanctioned vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC), a kinase inhibitor, for adult patients with symptomatic tenosynovial giant cel...
deciphera-pharmaceuticals

We Are Online! Chat With Us!
Scan the code